| abstract |
The present invention is a dual mode of action of the following: about group of novel phenylpiperazine derivatives which show partial agonism for the serotonin reuptake inhibitors and dopamine -D 2 receptors. The invention also relates to the use of the compounds disclosed herein in the manufacture of a medicament that provides a beneficial effect. This compound has the general formula (1): [Chemical 1] [Wherein the symbols have the meanings indicated herein] And the tautomers, stereoisomers and N-oxides thereof as well as the compounds represented by the above formula (1) and tautomers, stereoisomers and N-oxide drugs thereof Physiologically acceptable salts, hydrates and solvates. |